1-20 of 40
Rajeshwar Rao Tekmal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4813: ERX-208 as a novel therapeutic for treating ovarian cancer by enhancing endoplasmic reticulum stress

Suryavathi Viswanadhapalli, Tae-Kyung Lee, Kara Kassees, Gaurav Sharma, Rahul Gopalam, Karla Parra, Tanner Reese, Michael Hsieh, Uday P. Pratap, Xue Yang, Behnam Ebrahimi, Chia Yuan Chen, Scott Terry Elmore, Christian Cervantes, Zhenming Xu, Edward Kost, Gangadhara Reddy Sareddy, Rajeshwar Rao Tekmal, Jung-Mo Ann, Ganesh V. Raj, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4813.
https://doi.org/10.1158/1538-7445.AM2023-4813
Published: 04 April 2023
View article titled, Abstract 4813: ERX-208 as a novel therapeutic for treating ovarian cancer by enhancing endoplasmic reticulum stress
Journal Articles

Abstract 1237: Preclinical evaluation of ERX-41 in triple negative breast cancer

Suryavathi Viswanadhapalli, Xihui Liu, Shi-Hong Ma, Tae-Kyung Lee, Mengxing Li, Weiwei Tang, Junhao Liu, Xiaonan Li, Gangadhara R. Sareddy, Rajeshwar Rao Tekmal, Jung-Mo Ahn, Ratna K. Vadlamudi, Ganesh V. Raj
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1237.
https://doi.org/10.1158/1538-7445.AM2021-1237
Published: 01 July 2021
View article titled, Abstract 1237: Preclinical evaluation of ERX-41 in triple negative breast cancer
Journal Articles

Abstract PS17-09: Development of a potent mutant-ESR1 targeted agent, ERX-245, for treating metastatic therapy-resistant breast cancer

Ganesh V Raj, Suryavathi Viswanadhapalli, Karla Parra, Shihong Ma, Tae-Kyung Lee, Xihui Liu, Kara Kassees, Weiwei Tang, Junhao Liu, Zexuan Liu, Uday P Pratap, Behnam Ebrahimi, Rajeshwar Rao Tekmal, Jung-Mo Ann, Ratna K Vadlamudi
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS17-09.
https://doi.org/10.1158/1538-7445.SABCS20-PS17-09
Published: 15 February 2021
View article titled, Abstract PS17-09: Development of a potent mutant-ESR1 targeted agent, ERX-245, for treating metastatic therapy-resistant breast cancer
Journal Articles

Abstract 3485: PELP1 is a novel mediator of medulloblastoma progression

Yiliao Luo, Gangadhara Reddy Sareddy, Uday P. Pratap, Mengxing Li, Junhao Liu, Prabhakar Pitta-Venkata, Suryavathi Viswanadhapalli, Xiaonan Li, Manjeet Rao, Rajeshwar Rao Tekmal, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3485.
https://doi.org/10.1158/1538-7445.AM2019-3485
Published: 01 July 2019
View article titled, Abstract 3485: PELP1 is a novel mediator of medulloblastoma progression
Journal Articles

Abstract 280: Synthetic lethality of KDM1A and mTOR inhibitors: A novel combination therapy for endometrial cancer

Prabhakar Pitta-Venkata, Bridgitte Palacios, Yihong Chen, Suryavathi Viswanadhapalli, Uday P. Pratap, Yiliao Luo, Mengxing Li, Kristin Altwegg, Xiaonan Li, Takayoshi Suzuki, Rajeshwar Rao Tekmal, Edward Kost, Gangadhara Reddy Sareddy
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 280.
https://doi.org/10.1158/1538-7445.AM2019-280
Published: 01 July 2019
View article titled, Abstract 280: Synthetic lethality of KDM1A and mTOR inhibitors: A novel combination therapy for endometrial cancer
Journal Articles

Abstract 4316: Targeting LIFR overcomes HDAC inhibitor resistance in ovarian cancer

Mengxing Li, Suryavathi Viswanadhapalli, Gangadhara Reddy Sareddy, Bindu Santhamma, Hui Yan, Zhenming Xu, Edward Kost, Rajeshwar Rao Tekmal, Hareesh B. Nair, Klaus J. Nickisch, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4316.
https://doi.org/10.1158/1538-7445.AM2019-4316
Published: 01 July 2019
View article titled, Abstract 4316: Targeting LIFR overcomes HDAC inhibitor resistance in ovarian cancer
Journal Articles

Abstract 1712: Estrogen receptor beta signaling sensitizes glioblastoma cells to chemo and radiation therapy

Uday P. Pratap, Gangadhara Reddy Sareddy, Mengxing Li, Yiliao Luo, Mei Zhou, Suryavathi Viswanadhapalli, Rajeshwar Rao Tekmal, Andrew Brenner, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1712.
https://doi.org/10.1158/1538-7445.AM2019-1712
Published: 01 July 2019
View article titled, Abstract 1712: Estrogen receptor beta signaling sensitizes glioblastoma cells to chemo and radiation therapy
Journal Articles

Abstract 5875: Development of LIFR inhibitor EC359 as a novel therapeutic for ovarian cancer

Suryavathi Viswanadhapalli, Hareesh B Nair, Bindu Santhamma, Gangadhara R Sareddy, Yiliao Luo, Xinlei Pan, Edward R Kost, Ramachandran Murali, Rajeshwar Rao Tekmal, Klaus J Nickisch, Ratna K Vadlamudi
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5875.
https://doi.org/10.1158/1538-7445.AM2018-5875
Published: 01 July 2018
View article titled, Abstract 5875: Development of LIFR inhibitor EC359 as a novel therapeutic for ovarian cancer
Journal Articles

Abstract 4148: Novel ERX-11 and CDK4/6 inhibitor combination therapy for treating therapy resistant breast cancer

Suryavathi Viswanadhapalli, Gangadhara Reddy Sareddy, Shi-Hong Ma, Tae-Kyung Lee, Rajeshwar Rao Tekmal, Jung-Mo Ahn, Ganesh Raj, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4148.
https://doi.org/10.1158/1538-7445.AM2017-4148
Published: 01 July 2017
View article titled, Abstract 4148: Novel ERX-11 and CDK4/6 inhibitor combination therapy for treating therapy resistant breast cancer
Journal Articles

Abstract 860: ESR1 coregulator binding inhibitor (ECBI): a novel agent for treating hormone therapy-resistant breast cancer

Ratna K. Vadlamudi, Gangadhara Reddy Sareddy, Suryavathi Viswanadhapalli, Tae-Kyung Lee, Shi-Hong Ma, Wan Ru Lee, Monica Mann, Samaya Rajeshwari Krishnan, Vijay Gonugunta, Yang Liu, Douglas W. Strand, Rajeshwar Rao Tekmal, Jung-Mo Ahn, Ganesh V. Raj
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 860.
https://doi.org/10.1158/1538-7445.AM2016-860
Published: 15 July 2016
View article titled, Abstract 860: ESR1 coregulator binding inhibitor (ECBI): a novel agent for treating hormone therapy-resistant breast cancer
Journal Articles

Abstract 606: Therapeutic efficacy of ERβ agonists on ovarian cancer

Gangadhara Reddy Sareddy, Javier E. Chavez, Humberto Salazar, Monica Mann, Jocelyn Hernandez, Samaya Rajeshwari Krishnan, Edward Kost, Rajeshwar Rao Tekmal, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 606.
https://doi.org/10.1158/1538-7445.AM2014-606
Published: 01 October 2014
View article titled, Abstract 606: Therapeutic efficacy of ERβ agonists on ovarian cancer
Journal Articles

Abstract 1312: The estrogen receptor β agonists, Liquiritigenin and S-equol, inhibit breast cancer cell proliferation through the activation of tumor-suppressor and other pathways.

Cathy Samayoa, Anil Kotha, Naveen K. Krishnegowda, Ratna K. Vadlamudi, Rajeshwar Rao Tekmal
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1312.
https://doi.org/10.1158/1538-7445.AM2013-1312
Published: 15 April 2013
View article titled, Abstract 1312: The estrogen receptor β agonists, Liquiritigenin and S-equol, inhibit breast cancer cell proliferation through the activation of tumor-suppressor and other pathways.
Journal Articles

Abstract 953: Therapeutic significance of estrogen receptor ≤ agonists in gliomas

Gangadhara Reddy Sareddy, Binoj C. Nair, Vijaya K. Gonugunta, Quan-guang Zhang, Darrell W. Brann, Rajeshwar Rao Tekmal, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 953.
https://doi.org/10.1158/1538-7445.AM2012-953
Published: 15 April 2012
View article titled, Abstract 953: Therapeutic significance of estrogen receptor ≤ agonists in gliomas
Journal Articles

Abstract 2135: Proline, glutamic acid, leucine rich protein 1 (PELP1) is essential for optimal p53-mediated DNA damage response

Binoj C. Nair, Samaya R. Krishnan, Gangadhara R. Sareddy, Monica Mann, Bo Xu, Mohan Natarajan, Rajeshwar Rao Tekmal, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2135.
https://doi.org/10.1158/1538-7445.AM2012-2135
Published: 15 April 2012
View article titled, Abstract 2135: Proline, glutamic acid, leucine rich protein 1 (PELP1) is essential for optimal p53-mediated DNA damage response
Journal Articles

Abstract 2301: Epigenetic regulation of microRNA-200a and 141 by proto-oncogene PELP1: Role in breast cancer progression and metastasis

Sudipa Saha Roy, Manjeet Rao, Luzhe Sun, Rajeshwar Rao Tekmal, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2301.
https://doi.org/10.1158/1538-7445.AM2012-2301
Published: 15 April 2012
View article titled, Abstract 2301: Epigenetic regulation of microRNA-200a and 141 by proto-oncogene PELP1: Role in breast cancer progression and metastasis
Journal Articles

Abstract 5753: Potential therapeutic use of ER beta modulators in treating endocrine therapy resistant breast cancers

Rajeshwar Rao Tekmal, Manonmani Ganapathy, Anil K. Kotha, Naveen Krishnegowda, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5753.
https://doi.org/10.1158/1538-7445.AM2012-5753
Published: 15 April 2012
View article titled, Abstract 5753: Potential therapeutic use of ER beta modulators in treating endocrine therapy resistant breast cancers
Journal Articles

Abstract 2297: ERβ agonists reduce letrozole resistant breast cancer cell growth and diminish aromatase expression and activity

Manonmani Ganapathy, Hareesh Babu Nair, Nameer B. Kirma, Naveen Kumar Krishnegowda, Ratna Kumar Vadlamudi, Kusuma Kurmayagari, Mary Tagliaferri, Isaac Cohen, Rajeshwar Rao Tekmal
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2297.
https://doi.org/10.1158/1538-7445.AM2011-2297
Published: 15 April 2011
View article titled, Abstract 2297: ERβ agonists reduce letrozole resistant breast cancer cell growth and diminish aromatase expression and activity
Journal Articles

Cyclin-Dependent Kinase–Mediated Phosphorylation Plays a Critical Role in the Oncogenic Functions of PELP1

Binoj C. Nair, Sujit S. Nair, Dimple Chakravarty, Rambabu Challa, Bramanandam Manavathi, P. Renee Yew, Rakesh Kumar, Rajeshwar Rao Tekmal, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2010) 70 (18): 7166–7175.
https://doi.org/10.1158/0008-5472.CAN-10-0628
Published: 14 September 2010
View article titled, Cyclin-Dependent Kinase–Mediated Phosphorylation Plays a Critical Role in the Oncogenic Functions of PELP1
Open the PDF for Cyclin-Dependent Kinase–Mediated Phosphorylation Plays a Critical Role in the Oncogenic Functions of PELP1 in another window
Includes: Supplementary data
Journal Articles

Extranuclear Functions of ER Impact Invasive Migration and Metastasis by Breast Cancer Cells

Dimple Chakravarty, Sujit S. Nair, Bindu Santhamma, Binoj C. Nair, Long Wang, Abhik Bandyopadhyay, Joseph K. Agyin, Darrell Brann, Lu-Zhe Sun, I-Tien Yeh, Francis Y. Lee, Rajeshwar Rao Tekmal, Rakesh Kumar, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2010) 70 (10): 4092–4101.
https://doi.org/10.1158/0008-5472.CAN-09-3834
Published: 12 May 2010
View article titled, Extranuclear Functions of ER Impact Invasive Migration and Metastasis by Breast Cancer Cells
Open the PDF for Extranuclear Functions of ER Impact Invasive Migration and Metastasis by Breast Cancer Cells in another window
Journal Articles

Abstract 3669: PELP1: A novel therapeutic target for ovarian cancer progression and metastasis

Dimple Chakravarty, Rambabu Challa, Rajasekhar Dandamudi, Pablo Vivas-Mejia, Gabriel Lopez-Berestein, Rajeshwar Rao Tekmal, Anil K. Sood, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3669.
https://doi.org/10.1158/1538-7445.AM10-3669
Published: 15 April 2010
View article titled, Abstract 3669: PELP1: A novel therapeutic target for ovarian cancer progression and metastasis